secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2022-09-08T23:59:59+00:00
Accession:  0000721371-22-000101
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health announces Pharmaceutical Segment CEO change; Crawford out, Weitzman in
--------------------------------------------------------------------------------

- Victor Crawford to step down as Pharmaceutical Segment CEO effective Sept 19, 2022; will stay until Nov 13 for transition.
- Debbie Weitzman, former President of Pharmaceutical Distribution, named new CEO of Pharmaceutical Segment.
- Role of President of Pharmaceutical Distribution eliminated; segment restructured with additional role eliminations.
- Pharmaceutical and Specialty Distribution businesses will both report directly to Weitzman.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137122000101/0000721371-22-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137122000101/cah-20220907.htm
  HTML page:      https://secwatch.observer/filing/0000721371-22-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer